Stage IV adult sporadic Burkitt lymphoma/leukemia with complex bone marrow cytogenetics is associated with a very poor outcome

Blood. 2009 Jul 9;114(2):485-6; author reply 486-7. doi: 10.1182/blood-2009-03-213231.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Bone Marrow / metabolism*
  • Burkitt Lymphoma / diagnosis
  • Burkitt Lymphoma / drug therapy
  • Burkitt Lymphoma / genetics*
  • Burkitt Lymphoma / pathology*
  • Cytogenetics
  • Female
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Lymphoma, Large B-Cell, Diffuse / genetics
  • Lymphoma, Large B-Cell, Diffuse / metabolism
  • Lymphoma, Large B-Cell, Diffuse / pathology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Survival Rate
  • Treatment Outcome

Substances

  • Antineoplastic Agents